Director, U.S Customer Engagement, Strategic Alliances and Advocacy

About   Iovance Biotherapeutics, Inc.   Iovance Biotherapeutics , Inc.  is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. Amtagvi® (lifileucel) is the first FDA-approved, one-time treatment for previously treated advanced melanoma, now approved in three global markets and available at more than 95 authorized treatment centers. The  Iovance TIL platform  spans registrational trials and next-generation programs in additional solid tumors, including gene-edited and IL-12 tethered TIL therapies, next-generation IL-2, and precision immuno-oncology approaches. As the first and only company to take TIL therapy from concept to a broadly accessible commercial treatment, Iovance operates as an end-to-end cell therapy company, anchored by fully owned, centralized U.S.-based manufacturing that is scaled to serve thousands of cancer patients worldwide each year. For more information, please visit  www.iovance.com . Amtagvi® and its accompanying design marks, Proleukin ® , Iovance ® , and IovanceCares™ are trademarks and registered trademarks of Iovance Biotherapeutics, Inc. or its subsidiaries. All other trademarks and registered trademarks are the property of their respective owners. Information on Iovance’s broad, industry-leading patent portfolio is available on the Intellectual Property page on  www.iovance.com . Overview The Director, U.S. Customer Engagement, Strategic Alliances and Advocacy is responsible for developing and executing stakeholder engagement strategies that advance awareness, adoption, and integration of AMTAGVI and Iovance's oncology pipeline programs. Reporting to the Senior Director, Global Customer Engagement, Strategic Alliances & Advocacy, this role leads regional engagement with patient advocacy organizations, oncology thought leaders, and professional societies across the United States. This individual will serve as a key field-based stakeholder engagement leader, building relationships with advocacy organizations, academic and community oncology experts, and professional societies across melanoma, lung cancer, sarcoma, and future solid tumor indications. A primary focus will be establishing and sustaining a strategic lung cancer stakeholder network to support pipeline development, launch readiness, and long-term market success. Essential Functions and Responsibilities Advocacy & Stakeholder Engagement • Develop and execute regional advocacy engagement strategies aligned with corporate and brand objectives. • Build and maintain relationships with national, regional, and local patient advocacy organizations across current and future oncology indications. • Support patient education, survivorship, community outreach, and advocacy initiatives. • Gather and communicate stakeholder insights to inform business strategy, customer engagement planning, and patient support efforts. Key Opinion Leader & Professional Society Engagement • Develop and maintain relationships with community and academic oncology thought leaders across current and pipeline indications. • Build and expand a strategic lung cancer and sarcoma stakeholder network, including experts in thoracic oncology, pulmonology, thoracic surgery, and related specialties. • Identify and engage emerging and established thought leaders to support pipeline milestones, clinical trial awareness, and launch readiness activities. • Maintain stakeholder maps, engagement plans, and account intelligence to support strategic decision-making. • Partner with Medical Affairs and Commercial teams to coordinate stakeholder engagement activities and ensure alignment of objectives. Congress & External Engagement • Lead planning and execution of regional society meeting